Puma Biotechnology's (NASDAQ:PBYI) Strong Earnings Are Of Good Quality

Simply Wall StNov 21 02:26

H.C. Wainwright Maintains Puma Biotechnology(PBYI.US) With Buy Rating, Maintains Target Price $7

Futu NewsNov 21 00:32 · Ratings

Buy Rating Reiterated for Puma Biotechnology Amid Promising Phase 2 Trial and Strategic FDA Engagement

TipRanksNov 21 00:15 · Ratings

Puma Biotechnology Launches Mid-Stage Trial of Alisertib to Treat Breast Cancer

MT NewswiresNov 20 22:40

Express News | Puma Biotechnology Announces Initiation of Alisca™-Breast1 Phase II Trial of Alisertib in Hormone Receptor-Positive, Her2-Negative Metastatic Breast Cancer

BreakingsNov 20 21:57

Puma Biotechnology, Inc. Just Beat EPS By 23%: Here's What Analysts Think Will Happen Next

Simply Wall StNov 9 22:21